Journal of Psoriasis and Psoriatic Arthritis最新文献_第5页

Corrigendum to Proportions of Biologic Discontinuation Among Psoriasis Patients With Metabolic Comorbidities. 伴有代谢合并症的银屑病患者生物停药比例的勘误表

Journal of Psoriasis and Psoriatic Arthritis Pub Date : 2023-10-01 Epub Date: 2023-08-23 DOI: 10.1177/24755303231195867

引用次数: 0

Corrigendum to A Case of Grover's Disease Secondary to Brodalumab Therapy for Psoriasis. 更正一例Brodalumab治疗银屑病继发Grover病

Journal of Psoriasis and Psoriatic Arthritis Pub Date : 2023-10-01 Epub Date: 2023-08-31 DOI: 10.1177/24755303231195863

引用次数: 0

Corrigendum to Likelihood of COVID-19 Vaccination Among Individuals Living With Psoriatic Disease: Results From a Large Real-World Survey. 银屑病患者接种COVID-19疫苗的可能性的勘误表:来自大型现实世界调查的结果

Journal of Psoriasis and Psoriatic Arthritis Pub Date : 2023-10-01 Epub Date: 2023-08-23 DOI: 10.1177/24755303231195873

引用次数: 0

Corrigendum to Nail Changes in Psoriasis: Correlation Between Onychoscopy and NAPSI Scoring. 银屑病指甲变化更正：甲癣镜检查与NAPSI评分的相关性

Journal of Psoriasis and Psoriatic Arthritis Pub Date : 2023-10-01 Epub Date: 2023-08-31 DOI: 10.1177/24755303231195872

引用次数: 0

A Systematic Review of Follicular Psoriasis: A Unique but Under-Recognized Entity. 毛囊性银屑病的系统评价：一种独特但未被充分认识的实体

Journal of Psoriasis and Psoriatic Arthritis Pub Date : 2023-10-01 Epub Date: 2023-08-24 DOI: 10.1177/24755303231196567

Kelli Jablon, Jonathan D Ho, Hye Jin Chung

{"title":"A Systematic Review of Follicular Psoriasis: A Unique but Under-Recognized Entity.","authors":"Kelli Jablon, Jonathan D Ho, Hye Jin Chung","doi":"10.1177/24755303231196567","DOIUrl":"10.1177/24755303231196567","url":null,"abstract":"Background: Follicular psoriasis (FP) is a rare and under-recognized subtype of psoriasis that affects hair follicles and can be frequently misdiagnosed due to its unique presentation.Objective: We aimed to analyze the frequently reported clinical, histological, and dermatoscopic features of FP, as well as their treatment options.Methods: We conducted a systematic review of the PubMed/MEDLINE database using the search terms \"follicular\" and \"psoriasis.\" Fourteen studies were included yielding information on 44 patients (27 adults [61.4%] and 17 children [38.6%]).Results: Adult FP showed a female predominance (M:F = 1:2.7), frequent involvement of lower extremities (81.5%), association with metabolic syndrome including diabetes mellitus (22.2%), and a predilection for skin of color (SOC:White = 8:1). On the contrary, juvenile FP revealed male predominance (M:F = 1:0.6), frequent involvement of the trunk (41.2%), and exclusive involvement in skin of color (SOC:White = 11:0). In addition to its unique presentation, FP tends to be misdiagnosed due to its low incidence of concomitant psoriasis (31.8%), and rare personal (18.2%) or family history (6.8%) of psoriasis. Reported histopathological features include keratotic plugging, follicular parakeratosis with or without neutrophils, psoriasiform acanthosis, hypogranulosis, and neutrophilic infiltration of follicular epithelium. Dermatoscopic findings include folliculocentric lesions with normal appearing terminal hairs, perifollicular white scale, and various vascular structures.Conclusion: Once correctly diagnosed, patients with FP showed improvement or resolution of symptoms with various combinations of topical and systemic therapies. Understanding the demographic features and clinical presentations of FP can help address under-recognition of this clinical variant of psoriasis.","PeriodicalId":36656,"journal":{"name":"Journal of Psoriasis and Psoriatic Arthritis","volume":" ","pages":"141-147"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11361531/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46660247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Correlation Between Insulin Resistance and Psoriatic Arthritis Disease Activity: A Cross-Sectional Study. 胰岛素抵抗与银屑病关节炎活动性的相关性研究

Journal of Psoriasis and Psoriatic Arthritis Pub Date : 2023-10-01 Epub Date: 2023-05-31 DOI: 10.1177/24755303231180508

Yuliasih Yuliasih, Martino Handoyo, Lita Diah Rahmawati, Sony Wibisono, Nabilatun Nisa

{"title":"Correlation Between Insulin Resistance and Psoriatic Arthritis Disease Activity: A Cross-Sectional Study.","authors":"Yuliasih Yuliasih, Martino Handoyo, Lita Diah Rahmawati, Sony Wibisono, Nabilatun Nisa","doi":"10.1177/24755303231180508","DOIUrl":"10.1177/24755303231180508","url":null,"abstract":"Objectives: Most psoriatic arthritis (PsA) research and studies focus solely on the skin and joint manifestations, but there is also an increased risk of metabolic disorders, including insulin resistance (IR). This study aims to discover the relationship between IR and disease activity (DA) in PsA and its phenotype.Materials and methods: Patients with PsA classified using the CASPAR criteria with the disease activity was measured using the DAPSA score, and IR was identified as an elevated HOMA-IR of >2.5. The disease phenotype was determined with Moll and Wright's classification of the PsA subtype. The Pearson correlation test examined the relationship between DA and IR. The descriptive analysis was conducted to determine the relationship between the DAPSA score and HOMA-IR value in each PsA phenotype. All tests were two-tailed, analysed with GraphPad Prism 9, and a P-value of less than .05 was considered statistically significant.Results: From thirty-one patients, there was a strong and positive relationship between DA and IR (r = .768, P = .000). We also observed variations in DAPSA score and HOMA-IR value across different phenotypes, with symmetrical polyarthritis exhibiting the highest DAPSA score (21.55 ± 3.50) and HOMA-IR value (2.913 ± .5392) despite asymmetrical oligoarthritis that being the most frequent phenotype.Conclusion: Our study revealed a significant association between disease activity and insulin resistance in PsA patients, with the symmetrical polyarthritis phenotype demonstrating the highest levels of DAPSA score and IR value. This finding allowed rheumatologists to behold this manifestation and could improve PsA patients' long-term outlook.","PeriodicalId":36656,"journal":{"name":"Journal of Psoriasis and Psoriatic Arthritis","volume":" ","pages":"129-133"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11361538/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47232369","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Corrigendum to Practice Patterns of Palmoplantar Pustulosis: Patient Demographics and Treatment Options. 掌跖脓疱病的实践模式的勘误表:患者人口统计和治疗方案

Journal of Psoriasis and Psoriatic Arthritis Pub Date : 2023-10-01 Epub Date: 2023-08-23 DOI: 10.1177/24755303231195875

引用次数: 0

Corrigendum to Successful Treatment of Guttate Psoriasis With Ixekizumab: A Case Series. Ixekizumab成功治疗口腔银屑病的更正：一系列病例

Journal of Psoriasis and Psoriatic Arthritis Pub Date : 2023-10-01 Epub Date: 2023-08-31 DOI: 10.1177/24755303231195862

引用次数: 0

Paradoxical Effects of Depression on Psoriatic Arthritis Outcomes in a Combined Psoriasis-Psoriatic Arthritis Center 抑郁对银屑病-银屑病关节炎联合中心银屑病关节炎结局的矛盾影响

Journal of Psoriasis and Psoriatic Arthritis Pub Date : 2023-06-26 DOI: 10.1177/24755303231186405

Rebecca H. Haberman, Seungha Um, Sydney Catron, Alan Chen, Eileen Lydon, Malavikalakshmi Attur, Andrea L. Neimann, Soumya Reddy, Andrea Troxel, Samrachana Adhikari, Jose U. Scher

{"title":"Paradoxical Effects of Depression on Psoriatic Arthritis Outcomes in a Combined Psoriasis-Psoriatic Arthritis Center","authors":"Rebecca H. Haberman, Seungha Um, Sydney Catron, Alan Chen, Eileen Lydon, Malavikalakshmi Attur, Andrea L. Neimann, Soumya Reddy, Andrea Troxel, Samrachana Adhikari, Jose U. Scher","doi":"10.1177/24755303231186405","DOIUrl":"https://doi.org/10.1177/24755303231186405","url":null,"abstract":"Backgroud Psoriatic arthritis (PsA) is a chronic, inflammatory arthritis that, when left untreated, can lead to erosions, deformities and decrease in quality of life. PsA is known to be associated with multiple comorbidities, including cardiovascular, metabolic and mental health syndromes, all of which can increase its overall morbidity and mortality. Objective To characterize a cohort of patients with PsA and understand the impact of depression on PsA outcome measures. Methods 527 consecutive patients with PsA were enrolled in an observational, longitudinal registry that followed them prospectively at standard of care visits. Demographics, medical history, medication use, and clinical exam were all recorded. Results Depression was reported in 22.8% of the population, anxiety in 18%, and attention deficit hyperactivity disorder in 4%. Depression was more common in female participants (P < .001). At baseline, individuals with PsA and concomitant depression had similar tender and swollen joint counts and RAPID3 compared to those without depression, and had lower body surface area affected by psoriasis (P = .04). At year one, all patients had improvement in clinical outcomes. However, patients with depression had a significantly higher tender joint count compared to those without depression (P = .001), despite similar swollen joint count and body surface area. Conclusion In patients with depression, there is a discrepancy between improvement in physician assessed measures and patient reported outcomes. These observations underscore the importance of addressing depression and psychological distress as part of PsA treatment outcomes and points towards the need to address residual pain through co-adjuvant approaches.","PeriodicalId":36656,"journal":{"name":"Journal of Psoriasis and Psoriatic Arthritis","volume":"42 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135608493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

How to improve people-centred healthcare in dermatology? 如何改善皮肤科以人为本的医疗保健?

Journal of Psoriasis and Psoriatic Arthritis Pub Date : 2023-06-20 DOI: 10.55788/27076e04

R. Sommer, M. Augustin

{"title":"How to improve people-centred healthcare in dermatology?","authors":"R. Sommer, M. Augustin","doi":"10.55788/27076e04","DOIUrl":"https://doi.org/10.55788/27076e04","url":null,"abstract":"People with chronic skin diseases, such as psoriasis, experience multifaceted impairments that include physical symptoms, such as pain, psychological symptoms, such as anxiety, and social impairments, such as stigmatisation. To address this broad spectrum of impairments, a holistic healthcare approach is needed. The World Health Organization has established the people-centred model of care, in which health services adopt the perspective of people affected and their environment. The needs of patients are respected, and patients are put at the centre of care. This model was also adopted by the global report on psoriasis, which aims to improve the wellbeing of the affected people. This paper gives a brief overview of the status quo and an outline of how to improve people-centred care and patient orientation in dermatology, specifically for people with psoriasis. This includes the application of shared decision-making. Although only a few patient decision aids for psoriasis have been published, promising results regarding the reimbursement of shared decision-making applications in the hospital setting by health insurances are available, which also refer to dermatology departments. In addition, the use of patient-reported outcomes is of great importance to give patients a voice in their own healthcare. In accordance with the people-centred model, it is recommended to not only assess patients' perspectives, such as their needs, goals, and treatment benefits, but also the needs and treatment benefits of the patients' environment, such as their partner and treating healthcare professionals. One recent example of such a people-centred approach is the POSITIVE-study, which is the first study assessing the treatment effect on the wellbeing of patients with psoriasis. Moreover, the treatment benefit on physicians' satisfaction and patients' partners' lives is being evaluated. Therefore, it could act as a best practice example of how to integrate a people-centred approach in research.","PeriodicalId":36656,"journal":{"name":"Journal of Psoriasis and Psoriatic Arthritis","volume":"68 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75103410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0